KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024)

Bionano Genomics' Other Operating Expenses history spans 6 years, with the latest figure at $3000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 99.99% year-over-year to $3000.0; the TTM value through Sep 2025 reached $137000.0, down 99.52%, while the annual FY2024 figure was $27.7 million, 64.49% down from the prior year.
  • Other Operating Expenses for Q3 2025 was $3000.0 at Bionano Genomics, up from -$2000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $77.3 million in Q3 2023 and bottomed at -$2000.0 in Q2 2022.
  • The 5-year median for Other Operating Expenses is $438500.0 (2023), against an average of $10.6 million.
  • The largest annual shift saw Other Operating Expenses crashed 300.0% in 2022 before it crashed 71.89% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $1000.0 in 2021, then plummeted by 300.0% to -$2000.0 in 2022, then surged by 37150.0% to $741000.0 in 2023, then plummeted by 81.65% to $136000.0 in 2024, then plummeted by 97.79% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Other Operating Expenses are $3000.0 (Q3 2025), -$2000.0 (Q2 2025), and $136000.0 (Q4 2024).